Altimmune, Inc.
ALT
$3.32
-$0.04-1.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -91.76M | -91.08M | -88.09M | -83.92M | -87.75M |
| Total Depreciation and Amortization | 99.00K | 106.00K | 112.00K | 119.00K | 129.00K |
| Total Amortization of Deferred Charges | 397.00K | 0.00 | 0.00 | 171.00K | 58.00K |
| Total Other Non-Cash Items | 13.86M | 14.65M | 13.69M | 11.68M | 10.32M |
| Change in Net Operating Assets | 895.00K | 4.69M | 6.75M | 5.60M | -4.33M |
| Cash from Operations | -76.51M | -71.64M | -67.54M | -66.35M | -81.57M |
| Capital Expenditure | -54.00K | -32.00K | -11.00K | -10.00K | -10.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -453.56M | -131.03M | -132.46M | -39.67M | 110.85M |
| Cash from Investing | -453.61M | -131.06M | -132.47M | -39.68M | 110.84M |
| Total Debt Issued | 20.00M | 34.60M | 34.60M | 14.60M | 14.60M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 392.06M | 218.61M | 174.27M | 122.71M | 83.31M |
| Repurchase of Common Stock | -720.00K | -720.00K | -703.00K | -680.00K | -684.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.32M | -1.29M | -1.32M | -828.00K | -506.00K |
| Cash from Financing | 410.02M | 251.20M | 206.84M | 135.80M | 96.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -120.10M | 48.50M | 6.83M | 29.76M | 125.98M |